Status:
UNKNOWN
Diastolic Heart Failure Management by Nifedipine
Lead Sponsor:
Demand Investigators
Conditions:
Diastolic Heart Failure
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Patients with heart failure with preserved ejection fraction have a equally high risk for mortality and re-hospitalization as those with reduced ejection fraction. Effective management strategies are ...
Eligibility Criteria
Inclusion
- 20 years and older
- Heart failure with history of hypertension and/or coronary artery disease
- LVEF \> or = 50% on echocardiography
Exclusion
- Valvular heart diseases with significant regurgitation and/or stenosis
- Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and active myocarditis
- Constrictive pericarditis
- Cardiogenic shock
- Planned coronary artery bypass grafting or percutaneous coronary intervention within 3 months
- History of acute coronary syndrome or stroke within 3 months
- Pregnancy or breastfeeding
- Hypersensitivity or contraindication to nifedipine
- Inability to obtain informed consent
- Any conditions not suitable for the participation in this trial judged by the investigator
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT01157481
Start Date
July 1 2010
End Date
December 1 2016
Last Update
January 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hokkaido Univestity Hospital
Sapporo, Japan, 060-8638